US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Allenex receives part of €2.6M EU grant in collaboration with EUROSTAM

Allenex announces that Allenex group company AbSorber, together with EUROSTAM, a consortium of European Transplant Centers, has been supported by a € 2.6 million grant as part of the European Commission 7th framework programme (FP7). This is part of an ongoing Europe-wide strategy to enhance transplantation of highly sensitized patients where risk of complication is high due to genetic mismatches. The main objective of the three year project is to determine the clinical value of implementing a Europe-wide acceptable HLA mismatch program to facilitate more as well as safer transplantations

LinkMed acquire major sales channel

LinkMed acquires NorDiag´s 50 percent stake in Olerup International AB, which is the holding company for Olerup GmbH. LinkMed will thereby control 75 percent of the company. Both sales and earnings are consolidated into the Group as of June 1, 2011. Net sales are expected to increase on an annual basis by approximately SEK 28 million and the profit on EBIT level of SEK 8-10 million.LinkMed increases its ownership in Olerup International AB to 75 percent by acquiring NorDiag 50 percent stake in Olerup International AB which is the holding company of Olerup GmbH. The remaining 25 percent of

Increased focus on the transplantation sector

The Board of Directors of LinkMed today announced a strategic decision to further focus the company’s operations on the transplantation sector. Consequently, LinkMed will work actively to find additional acquisitions in the sector and continue its global efforts in Olerup SSPs and AbSorber’s product area. Going forward, LinkMed will prioritize investment in this sector. At the same time, the company will intensify work to realize the value of the portfolio of life science companies built up since 1998. In the long-term, LinkMed’s operations will essentially be focused on the transplantation

AbSorber receives European patent protection for its transplantation cross match-test XM-ONE

LinkMed’s subsidiary AbSorber has received patent protection for its transplantation cross match-test XM-ONE® in the European countries. The patent was previously approved in New Zealand which was the first country to approve a patent for AbSorbers product. The European countries are highly prioritized markets for AbSorber and the patent approval is an important milestone in Absorbers intellectual property strategy.The patent was granted by the European Patent Office (EPO) and AbSorber has also patent applications pending for XM-ONE® in the US, Japan and in other key transplantation markets.

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media